T. Maughan

6LBA Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)

T. Maughan, Richard Adams, Charlotte G. Smith et al. · European Journal of Cancer Supplements · 2009 · 44 citations

Medicine, Oncology, Pharmacology +14

Addition of panitumumab to irinotecan: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC).

Michel Seymour, Sherry-Ann Brown, Susan D. Richman et al. · Journal of Clinical Oncology · 2011 · 26 citations

Medicine, Oncology, Pharmacology +16

Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC)

Rob Glynne‐Jones, David Sebag‐Montefiore, Leslie Samuel et al. · Journal of Clinical Oncology · 2005 · 24 citations

Medicine, Oncology, Radiation Oncology +17

Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimens in the palliative chemotherapy of advanced colorectal cancer (CRC): Final results of MRC CR06

T. Maughan, R.D. James, David Kerr et al. · UCL Discovery (University College London) · 2000 · 21 citations

Medicine, Oncology, Pharmacology +13